Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia | New England Journal of Medicine | 2017 | 926 |
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis | Ultrasound in Obstetrics and Gynecology | 2015 | 419 |
Competing risks model in early screening for preeclampsia by biophysical and biochemical markers | Fetal Diagnosis and Therapy | 2013 | 359 |
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Ultrasound in Obstetrics and Gynecology | 2015 | 353 |
Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks | Prenatal Diagnosis | 2011 | 312 |
New insights into the epidemiology of childhood atopic dermatitis | Allergy: European Journal of Allergy and Clinical Immunology | 2014 | 293 |
Internal fixation versus hemiarthroplasty versus total hip arthroplasty for displaced subcapital fractures of femur--13 year results of a prospective randomised study | Injury | 2000 | 266 |
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation | American Journal of Obstetrics and Gynecology | 2016 | 251 |
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | New England Journal of Medicine | 2016 | 244 |
A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement | Bone and Joint Journal | 2014 | 212 |
Competing risks model in screening for preeclampsia by maternal characteristics and medical history | American Journal of Obstetrics and Gynecology | 2015 | 198 |
ASPRE trial: performance of screening for preterm pre-eclampsia | Ultrasound in Obstetrics and Gynecology | 2017 | 161 |
Combined screening for preeclampsia and small for gestational age at 11-13 weeks | Fetal Diagnosis and Therapy | 2013 | 159 |
Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations | Ultrasound in Obstetrics and Gynecology | 2017 | 150 |
Screening for dementia in primary care: a review of the use, efficacy and quality of measures | International Psychogeriatrics | 2008 | 150 |
Oral appliances for obstructive sleep apnoea | The Cochrane Library | 2006 | 150 |
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation | Ultrasound in Obstetrics and Gynecology | 2017 | 138 |
British Society of Gastroenterology/Association of Coloproctologists of Great Britain and Ireland guidelines for the management of large non-pedunculated colorectal polyps | Gut | 2015 | 137 |
Clinical features of boys with fragile X premutations and intermediate alleles | American Journal of Medical Genetics Part A | 2003 | 133 |
Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE | Ultrasound in Obstetrics and Gynecology | 2018 | 131 |
Anterior knee pain: a long-term follow-up | British Journal of Rheumatology | 2003 | 125 |
Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis | Ultrasound in Obstetrics and Gynecology | 2019 | 121 |
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery | Blood Coagulation and Fibrinolysis | 2000 | 119 |
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation | Ultrasound in Obstetrics and Gynecology | 2018 | 118 |
Surgery for obstructive sleep apnoea | The Cochrane Library | 2005 | 117 |